BioAge Labs, Inc.
(BIOA - NASDAQ)
18,06 USD
📋 Profilo Aziendale

BioAge Labs, Inc. is a clinical-stage biopharmaceutical company that develops therapeutic product candidates for metabolic diseases.

|